TRIM33 and cancer: Cytokine levels could have fluctuated after treatment, although no significant difference was observed in the medication differences regarding DM between the Cancer TIF1-γ-DM and the Non-cancer TIF1-γ-DM groups (Table 1), cancer treatment may influence cytokine levels.